|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2010-8-20
|
|
pubmed:abstractText |
Pancreatic cancer is one of the most deadly cancers, and serum carbohydrate antigen 19-9 (CA19-9) level has been reported to be a useful prognostic marker in pancreatic cancer. The purpose of this study was to determine which prognostic factor (preoperative or postoperative serum CA19-9 level) is more useful.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1534-4681
|
|
pubmed:author |
pubmed-author:HashimotoYasushiY,
pubmed-author:HayashidaniYasuoY,
pubmed-author:KatoYasushiY,
pubmed-author:KondoNaruN,
pubmed-author:MurakamiYoshiakiY,
pubmed-author:NakashimaAkiraA,
pubmed-author:OhgeHirokiH,
pubmed-author:SakabeRyutaroR,
pubmed-author:ShigemotoNorifumiN,
pubmed-author:SudoTakeshiT,
pubmed-author:SuedaTaijiroT,
pubmed-author:UemuraKenichiroK
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2321-9
|
|
pubmed:meshHeading |
pubmed-meshheading:20336387-Adenocarcinoma,
pubmed-meshheading:20336387-Adult,
pubmed-meshheading:20336387-Aged,
pubmed-meshheading:20336387-Aged, 80 and over,
pubmed-meshheading:20336387-CA-19-9 Antigen,
pubmed-meshheading:20336387-Carcinoma, Pancreatic Ductal,
pubmed-meshheading:20336387-Combined Modality Therapy,
pubmed-meshheading:20336387-Female,
pubmed-meshheading:20336387-Humans,
pubmed-meshheading:20336387-Lymphatic Metastasis,
pubmed-meshheading:20336387-Male,
pubmed-meshheading:20336387-Middle Aged,
pubmed-meshheading:20336387-Neoplasm Invasiveness,
pubmed-meshheading:20336387-Neoplasm Staging,
pubmed-meshheading:20336387-Pancreatic Neoplasms,
pubmed-meshheading:20336387-Perioperative Period,
pubmed-meshheading:20336387-Prognosis,
pubmed-meshheading:20336387-Retrospective Studies,
pubmed-meshheading:20336387-Survival Rate,
pubmed-meshheading:20336387-Tumor Markers, Biological
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer.
|
|
pubmed:affiliation |
Department of Surgery, Division of Clinical Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan. k-naru@par.odn.ne.jp
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
